Drug Safety Newsletter - 36th Edition
01 April 2010
Topics covered in this edition of the Drug Safety Newsletter include:
Vigabatrin (Sabril)
HRT – Product Information Update
Natalizumab (Tysabri)
Epoetins – Product Information
Fluoxetine and risk of cardiovascular birth defects
Fentanyl Transdermal Patches
Avoiding Medication Errors with Perindopril Arginine/Amlodipine (Acerycal) Combination Products
Drug Safety Newsletter - 36th Edition